Synthetic Biology & Biomanufacturing Branding Agency
The strain performs at bench scale. The contract is signed at commercial.
We brand synthetic biology and biomanufacturing companies. Titre, rate, yield. Then the questions that actually decide it: at what scale, at what cost per kilogram, and can you deliver that every quarter for five years. Your buyer is a procurement team holding you against a petrochemical incumbent with forty years of supply history and a price you have to beat.
What a synthetic biology & biomanufacturing branding agency does
A synthetic biology & biomanufacturing branding agency positions and explains synthetic biology, biomanufacturing, precision fermentation, engineered enzyme, biomaterials and cell programming companies so technical and financial buyers can judge the purchase rather than the demonstration. Everything Deep Tech builds category and positioning, naming, narrative and messaging, evidence architecture, visual identity and brand book.
| Best for | Synthetic biology, biomanufacturing, precision fermentation, engineered enzyme, biomaterials and cell programming companies. |
|---|---|
| What goes wrong | A titre proves a strain. It does not prove a supply. |
| What you get | Category and positioning, naming, narrative and messaging, evidence architecture, visual identity, brand book. Ingredient, molecule, platform or contract manufacturer. Where you sit against the petrochemical incumbent and against the option of doing nothing. |
| Timeline | 9–16 weeks from kickoff to a finished brand system. Fixed scope, fixed timeline, one price. |
| Buyers held in one brand | the scientist who reads the titre, the procurement lead who reads the price. |
| Category | Molecule, ingredient, material or process. The market has learned what platform means when no product sits behind it, and the word now costs you something. |
A titre proves a strain. It does not prove a supply.
Five reasons a studio that does good work for software brands produces something thin for a synthetic biology company.
- →Platform is a damaged word. The category sold organism-agnostic platforms for a decade and the market repriced them hard. Used without a product behind it, the word now subtracts credibility rather than adding it.
- →Scale-up is the whole risk. Everything works at ten litres. The distance from a flask to a hundred cubic metres is where these companies die, and a brand that skips it reads as naive to anyone who has run a plant.
- →The buyer is procurement. A chemicals, food or materials company is weighing your molecule on price, purity, volume and security of supply. The elegance of the pathway is not on their sheet.
- →The numbers are the argument. Titre, rate, yield and cost per kilogram are the working vocabulary. A studio that treats them as detail to be simplified deletes the only content the reader came for.
- →Green is table stakes. Every competitor claims a lower footprint. An unquantified sustainability claim is noise, and in a growing number of jurisdictions it is also a legal exposure.
Positioning first, identity second.
Category and positioning
Ingredient, molecule, platform or contract manufacturer. Where you sit against the petrochemical incumbent and against the option of doing nothing.
Naming
Company, platform, organism and product. A system that survives the pivot from one feedstock or molecule to the next.
Narrative and messaging
The scale-up story told straight: where you are today, what is proven, what is next, and what it costs to get there.
Evidence architecture
Titre, rate, yield, cost curve and lifecycle figures structured so a fermentation scientist and a procurement lead each find their own.
Visual identity
A system that reads as an industrial supplier rather than a university group, and holds on a fermenter, a drum and a certificate of analysis.
Brand book
Rules tight enough to hold when your team applies them without us.
The translation is the product everyone else is missing.
Weeks from kickoff to a finished brand system. Fixed scope, fixed timeline, one price.
Engineers across strategy, 3D, delivery and the build. The person writing your scale-up story has shipped hardware.
Buyers held in one brand: the scientist who reads the titre, the procurement lead who reads the price.
Positioning decides what the brand claims. The website is where a specialist decides whether to believe it.
Synthetic biology branding questions, from founders.
How is this different from your biotech pages?
Biotech there is trials, endpoints and reimbursement, where a regulator decides. Synthetic biology here is an industrial supply decision: scale, cost per kilogram and security of supply. A company with both a therapeutic and a manufacturing arm usually needs the two pages read together.
We are pre-commercial. Is it too early?
No, but the brand has to say so. The expensive mistake is implying a scale you do not have; partners check, and one corrected overstatement costs more than the honest version ever would.
What does it cost?
Fixed scope and fixed timeline, quoted after the 30-minute call. Never a day rate and never an open-ended retainer.
How long does it take?
Nine to sixteen weeks for positioning, narrative, identity and brand book. Fixed scope, fixed timeline, one price.
Do you sign NDAs before seeing the technology?
Yes, and it is the normal starting point. Most of what makes a deep tech company defensible is unpublished.
Send us the cost model and your current scale.
Thirty minutes, no deck. We will tell you which category you are being read into, which part of your advantage is invisible on the page, and what we would change first.
Book a 30-minute audit →